Monday, October 26, 2026 · Daily editionET --:--:--

By invitation only

National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric Cancer

NCT06242613 · Hospital Universitario de Gran Canaria Doctor Negrín · Updated 5 Feb 2024

What is being tested
Robot-Assisted Gastrectomy; Laparoscopic Gastrectomy
For
Gastric Cancer
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 400 people. The full rules are on the registry page.
Where
Spain
When
Starts or started 13 May 2023, ends 31 Dec 2029. Registered 5 Feb 2024.
Results
None posted yet.

In the researchers' words

In recent years there has been a rapid incursion of robotic technology applied to almost all fields of surgery. In gastric cancer, whose mainstay of treatment is still surgical resection, gastrectomy with robotic lymphadenectomy is growing faster than the scientific evidence supporting its results. The "National Multicenter Cohort Study of ROBOT-Assisted Gastrectomy Versus Laparoscopy in Gastric Cancer" (ROBOTAG study) is proposed as a prospective multicenter Spanish nationwide study, comparing robotic gastrectomy versus conventional laparoscopic gastrectomy for the treatment of gastric cancer. This study aims to provide evidence on the feasibility, safety and complications, possible technical advantages, short and long term surgical and oncological results, as well as aspects related to quality of life, which can support the increase in cost and the important technological effort that underlies robotic surgery with respect to conventional laparoscopic access. The relevance of this project is doubled by directing the objectives, on the one hand, on a new and expensive technology that is reaching hospitals still surrounded by controversy about its real benefits; and on the other hand, by acting on a pathology for which most of the available studies come from Eastern countries, sometimes not very applicable to the Western context.
ClinicalTrials.gov, NCT06242613

Sites

  • Mª Asunción Acosta MéridaLas Palmas de Gran Canaria, Las Palmas, Spain